Chaofan Fan
Overview
Explore the profile of Chaofan Fan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Fan C, Li T, Chen R, Liu Q, Gong J
Big Data
. 2024 Jul;
PMID: 38984408
Extracting meaningful patterns of human mobility from accumulating trajectories is essential for understanding human behavior. However, previous works identify human mobility patterns based on the spatial co-occurrence of trajectories, which...
2.
Wang K, Nguyen T, Gao Y, Guo R, Fan C, Liao H, et al.
Insect Biochem Mol Biol
. 2024 May;
170:104137.
PMID: 38759703
Scorpion venom is a potent natural source for antitumor drug development due to the multiple action modes of anticancer components. Although the sequence of Androcin 18-1 has been identified from...
3.
4.
Shen L, Yin H, Sun L, Zhang Z, Jin Y, Cao S, et al.
Arthritis Res Ther
. 2024 Jan;
26(1):34.
PMID: 38254215
No abstract available.
5.
Ghasemi A, Martinez-Usatorre A, Li L, Hicham M, Guichard A, Marcone R, et al.
Nat Cancer
. 2023 Nov;
5(2):240-261.
PMID: 37996514
Dendritic cells (DCs) are antigen-presenting myeloid cells that regulate T cell activation, trafficking and function. Monocyte-derived DCs pulsed with tumor antigens have been tested extensively for therapeutic vaccination in cancer,...
6.
Shen L, Yin H, Sun L, Zhang Z, Jin Y, Cao S, et al.
Arthritis Res Ther
. 2023 Aug;
25(1):151.
PMID: 37596660
Background: The early growth response 1 (EGR1) is a central transcription factor involved in systemic sclerosis (SSc) pathogenesis. Iguratimod is a synthesized anti-rheumatic disease-modifying drug, which shows drastic inhibition to...
7.
Kotsiliti E, Leone V, Schuehle S, Govaere O, Li H, Wolf M, et al.
J Hepatol
. 2023 May;
79(2):296-313.
PMID: 37224925
Background & Aims: The progression of non-alcoholic steatohepatitis (NASH) to fibrosis and hepatocellular carcinoma (HCC) is aggravated by auto-aggressive T cells. The gut-liver axis contributes to NASH, but the mechanisms...
8.
Fan C, Li J, Li Y, Jin Y, Feng J, Guo R, et al.
Clin Transl Immunology
. 2023 May;
12(5):e1447.
PMID: 37179532
Objectives: Rheumatoid arthritis (RA) is a disease characterised by bone destruction and systemic inflammation, and interleukin-6 (IL-6) is a therapeutic target for treating it. The study aimed at investigating the...
9.
Leslie J, Mackey J, Jamieson T, Ramon-Gil E, Drake T, Fercoq F, et al.
Gut
. 2022 Apr;
PMID: 35477863
Objective: Hepatocellular carcinoma (HCC) is increasingly associated with non-alcoholic steatohepatitis (NASH). HCC immunotherapy offers great promise; however, recent data suggests NASH-HCC may be less sensitive to conventional immune checkpoint inhibition...
10.
Meng X, Guo R, Fan C, Li Y, Liu X, Chen X, et al.
Postepy Dermatol Alergol
. 2022 Apr;
39(1):72-80.
PMID: 35369615
Introduction: Psoriasis is an immune-mediated systemic disease. Neutrophils are enriched in psoriasis lesions and can form neutrophil extracellular traps (NETs) to activate keratinocytes. Receptor-interacting protein kinase RIPK1 and RIPK3 are...